Found 182 Diabetes Mellitus, Type 2 trials
A listing of Diabetes Mellitus, Type 2 medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
This open-label study is designed to evaluate the long-term safety and tolerability of acoramidis in participants with ATTR-CM, administered on a background of stable heart failure therapy. This study follows the randomized, double-blind, placebo-controlled Study AG10-301 which was designed to examine safety and efficacy in this same population.
The research study is being conducted to assess the role of Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET) imaging (a radiology scan) for monitoring the course of COVID-19 infection.
Some samples (for example, blood, tissue, fluids) taken from you during this or another research study might be useful for research at some later date. This study is being done so that your samples can be stored and used at some later date for research studies, including genetic testing. These …
This study is a prospective, multicenter, randomized controlled trial of the FlowTriever System plus anticoagulation compared to anticoagulation alone for intermediate-risk acute PE. Up to 1200 subjects with intermediate-risk acute PE will be randomized. All subjects who sign informed consent and who meet all of the inclusion criteria and none …
This is a multicenter, randomized, quadruple-blind, sham controlled, 2-part, embedded IDE clinical trial. The main objective is to evaluate the efficacy and safety of Cardiac Contractility Modulation (CCM) therapy in patients with symptomatic HF with LVEF 40-60%. The study is divided into 3 phases, screening, randomization (where 2/3 will be …
The INTEGRA D study will evaluate the safety and efficacy of the CCM D System in patients with heart failure symptoms despite being on GDMT and have an LVEF 40%.The This is designed as a single arm, prospective, multicenter study of 300 subjects that will establish that the device can …
PRIMARY OBJECTIVE: To demonstrate that treatment of Invasive Candidiasis/ Candidemia with IV echinocandin followed by oral ibrexafungerp is non-inferior to IV echinocandin followed by oral fluconazole based on 30-day all-cause mortality (ACM). SECONDARY OBJECTIVES: To demonstrate that treatment of Invasive Candidiasis/ Candidemia with intravenous (IV) echinocandin followed by oral ibrexafungerp …
This study aims to identify genotypic and phenotypic characteristics that are associated with the clinical heterogeneity and outcomes of hypertrophic cardiomyopathy (HCM), using the Sarcomeric Human Cardiomyopathy Registry (SHaRe).
The primary objective of this trial is to test whether FFRangio®-guided treatment is noninferior to conventional pressure wire-guided treatment in patients with coronary artery disease being evaluated for percutaneous coronary intervention (PCI) with respect to major adverse cardiac events (MACE) at one year
This study will test an experimental drug named Lenacapavir (LEN), also known as Sunlenca® for the prevention of HIV-1 infection. The other HIV and pre-exposure prophylaxis (PrEP) medication included in this study is F/TDF (brand name Truvada®) which contains emtricitabine (F) and tenofovir disoproxil fumarate (TDF). F/TDF is approved for …
